|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
13,380,000 |
Market
Cap: |
202.44(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$11.6 - $15.13 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Merrimack Pharmaceuticals is a biopharmaceutical company. Co. does not have any ongoing research or development activities.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
49,550 |
504,050 |
1,155,305 |
Total Buy Value |
$0 |
$651,754 |
$6,240,948 |
$13,468,612 |
Total People Bought |
0 |
1 |
2 |
4 |
Total Buy Transactions |
0 |
2 |
13 |
36 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Crocker Gary L |
Director |
|
2014-03-12 |
4 |
OE |
$1.25 |
$62,500 |
D/D |
50,000 |
2,728,271 |
|
- |
|
Sullivan William A. |
CFO and Treasurer |
|
2013-12-31 |
4 |
OE |
$1.81 |
$19,910 |
D/D |
11,000 |
11,000 |
|
- |
|
Porter Michael E |
Director |
|
2013-12-17 |
4 |
B |
$4.80 |
$59,939 |
D/D |
12,500 |
470,865 |
2.39 |
- |
|
Porter Michael E |
Director |
|
2013-12-16 |
4 |
B |
$4.71 |
$58,873 |
D/D |
12,500 |
458,365 |
2.39 |
- |
|
Mcclements William M. |
SVP of Corporate Operations |
|
2013-12-12 |
4 |
B |
$4.39 |
$10,981 |
D/D |
2,500 |
13,000 |
2.74 |
- |
|
Mcclements William M. |
SVP of Corporate Operations |
|
2013-12-11 |
4 |
B |
$4.05 |
$6,078 |
D/D |
1,500 |
10,500 |
2.74 |
- |
|
Porter Michael E |
Director |
|
2013-12-10 |
4 |
B |
$4.38 |
$78,840 |
D/D |
18,000 |
445,865 |
2.39 |
- |
|
Quigley James H. |
Director |
|
2013-12-06 |
4 |
B |
$4.70 |
$183,257 |
D/D |
39,000 |
51,500 |
2.39 |
- |
|
Mulroy Robert J. |
President and CEO |
|
2013-12-04 |
4 |
B |
$4.42 |
$146,226 |
D/D |
33,100 |
989,644 |
2.81 |
- |
|
Nash Sarah E |
Director |
|
2013-12-03 |
4 |
B |
$4.35 |
$2,175 |
D/D |
500 |
976,994 |
2.31 |
- |
|
Porter Michael E |
Director |
|
2013-12-03 |
4 |
B |
$4.25 |
$21,253 |
D/D |
5,000 |
427,865 |
2.39 |
- |
|
Mulroy Robert J. |
President and CEO |
|
2013-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,715 |
941,069 |
|
- |
|
Mulroy Robert J. |
President and CEO |
|
2013-12-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(58,290) |
931,354 |
|
- |
|
Nash Sarah E |
Director |
|
2013-12-02 |
4 |
B |
$4.17 |
$196,131 |
D/D |
47,000 |
976,494 |
2.39 |
- |
|
Porter Michael E |
Director |
|
2013-12-02 |
4 |
B |
$4.17 |
$291,655 |
D/D |
70,000 |
422,865 |
2.39 |
- |
|
Mcclements William M. |
SVP of Corporate Operations |
|
2013-12-02 |
4 |
B |
$4.06 |
$8,119 |
D/D |
2,000 |
9,000 |
2.74 |
- |
|
Sinskey Anthony J |
Director |
|
2013-11-29 |
4 |
B |
$3.92 |
$14,877 |
D/D |
3,800 |
392,543 |
2.39 |
- |
|
Porter Michael E |
Director |
|
2013-11-29 |
4 |
B |
$3.79 |
$94,830 |
D/D |
25,000 |
352,865 |
2.39 |
- |
|
Mcclements William M. |
SVP of Corporate Operations |
|
2013-11-29 |
4 |
B |
$3.91 |
$3,915 |
D/D |
1,000 |
7,000 |
2.66 |
- |
|
Crocker Gary L |
Director |
|
2013-11-27 |
4 |
B |
$3.71 |
$769,536 |
I/I |
207,000 |
2,678,271 |
2.1 |
- |
|
Porter Michael E |
Director |
|
2013-11-27 |
4 |
B |
$3.51 |
$175,355 |
D/D |
50,000 |
327,865 |
2.39 |
- |
|
Mcclements William M. |
SVP of Corporate Operations |
|
2013-11-27 |
4 |
B |
$3.56 |
$21,340 |
D/D |
6,000 |
6,000 |
2.74 |
- |
|
Mulroy Robert J. |
President and CEO |
|
2013-05-06 |
4 |
OE |
$2.19 |
$109,500 |
D/D |
50,000 |
956,544 |
|
- |
|
Stewart Edward J. |
SVP & Pres, Healthcare Sol |
|
2013-04-29 |
4 |
OE |
$2.19 |
$10,950 |
D/D |
5,000 |
21,385 |
|
- |
|
Dresser James Van B. |
Director |
|
2013-04-25 |
4 |
OE |
$2.19 |
$32,850 |
D/D |
15,000 |
143,974 |
|
- |
|
410 Records found
|
|
Page 14 of 17 |
|
|